- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Cancer Immunotherapy-Related Adverse Events and Therapy-Related Accelerated Aging
Deadline: 30 September 2026
Tumor-Initiating Cells in Cancer: Their Interactions with Other Cell Types, and Prospective Applications
Deadline: 30 September 2026
Multimodal Artificial Intelligence/Machine Learning Applications in Malignant Tumors: Diagnosis, Prognosis, and Management
Deadline: 30 September 2026
Medical Image-Based Cervical Cancer Prevention, Diagnosis and Treatments
Deadline: 30 September 2026
Advances in Combination Therapy for Lymphoma
Deadline: 30 September 2026
Breast Cancer and Pregnancy: Clinical, Translational, and Psychosocial Perspectives
Deadline: 30 September 2026
Beyond PEGylation: Next-Generation Nanomedicine for Cancer Therapy
Deadline: 30 September 2026
Psychological Factors and Cancer Survivorship
Deadline: 30 September 2026
Redefining Precision Radiotherapy
Deadline: 30 September 2026
Cancer Drug Resistance: Mechanisms and Overcoming Strategies
Deadline: 30 September 2026
Senescence and Cell Plasticity in Cancer Development
Deadline: 30 September 2026
Integrated Palliative Care in Advanced Cancer
Deadline: 30 September 2026
of 261

